RA Capital Management reports purchase of Artiva Biotherapeutics common shares worth $194,237.66

RA Capital Management, a director and 10% owner of Artiva Biotherapeutics, increased its stake by purchasing 21,654 common shares on the open market. The holding rose to 16,817,573 shares, with purchases made at weighted-average prices of USD 8.97 and USD 8.94, totaling approximately $194,237.66.

RA Capital Management, a director and 10% owner of Artiva Biotherapeutics, increased its stake through open-market common stock purchases. * Holding rose to 16,817,573 shares, reflecting net buying of 21,654 shares at weighted-average prices of USD 8.97 and USD 8.94. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000764), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

ARTV